Peerbocus Muaz, Wang Zeng-Jun
Department of Urology, Nanjing Medical University, Nanjing, People's Republic of China.
Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, People's Republic of China.
Res Rep Urol. 2021 Jul 29;13:535-547. doi: 10.2147/RRU.S307385. eCollection 2021.
Enhanced recovery after surgery (ERAS) protocols aim to optimize patient recovery after major surgery. Our study was to examine the evidence of the effectiveness of interventions designed to improve patient outcomes after radical cystectomy.
Systematic review and meta-analysis.
PubMed, Medline, Embase, Cochrane from January 2005 to January 2021 without language restrictions.
Randomized and non-randomized controlled studies implementing ERAS measuring its interventions on rates of postoperative complications, 30-day readmission, length of stay (LOS) and bowel function after radical cystectomy.
Two members of the investigating team independently selected studies and evaluated bias using the Cochrane collaboration tool. Meta-analysis of all comparative studies used inversed-weighted, fixed- effects models and random effects models to pool results. Publication bias was graphically assessed using contour-enhanced funnel plots and the Egger's test of funnel plot symmetry.
Fifteen studies were included in our meta-analysis; we observed that ERAS decreased the time for the first bowel movement (standardized mean difference [SMD]: -1.30, 95% CI -1.90 to -0.70, P<0.00001) and shortened the length of stay (LOS) ([SMD]: -0.49, 95% CI -0.77 to -0.20, (P < 0.00001)); however, 30-day readmission (risk ratio [RR]: 0.97,95% [CI] 0.73 to 1.28, P=0.52) and the overall postoperative complication rate (risk ratio [RR]: 0.98,95% confidence interval [CI]: 0.88 to 1.09, P= 0.41) showed no significant difference.
术后加速康复(ERAS)方案旨在优化大手术后患者的康复情况。我们的研究旨在检验旨在改善根治性膀胱切除术后患者预后的干预措施有效性的证据。
系统评价和荟萃分析。
2005年1月至2021年1月期间的PubMed、Medline、Embase、Cochrane数据库,无语言限制。
实施ERAS的随机和非随机对照研究,测量其对根治性膀胱切除术后并发症发生率、30天再入院率、住院时间(LOS)和肠道功能的干预措施。
研究团队的两名成员独立选择研究,并使用Cochrane协作工具评估偏倚。对所有比较研究进行荟萃分析时,使用逆加权固定效应模型和随机效应模型汇总结果。使用等高线增强漏斗图和Egger漏斗图对称性检验以图形方式评估发表偏倚。
我们的荟萃分析纳入了15项研究;我们观察到ERAS缩短了首次排便时间(标准化均数差[SMD]:-1.30,95%可信区间-1.90至-0.70,P<0.00001)并缩短了住院时间(LOS)([SMD]:-0.49,95%可信区间-0.77至-0.20,P<0.00001);然而,30天再入院率(风险比[RR]:0.97,95%[CI]0.73至1.28,P=0.52)和总体术后并发症发生率(风险比[RR]:0.98,95%可信区间[CI]:0.88至1.09,P=0.41)无显著差异。